Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of Transient Receptor Potential Melastain 7 Enhances Apoptosis Induced by TRAIL in PC-3 cells

  • Lin, Chang-Ming (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Ma, Ji-Min (Emergency medical center, The Central Hospital of Maanshan The Affiliated Hospital of Wannan Medical College) ;
  • Zhang, Li (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Hao, Zong-Yao (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Zhou, Jun (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Zhou, Zhen-Yu (The First people's hospital of Suqian) ;
  • Shi, Hao-Qiang (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Zhang, Yi-Fei (Department of Urology, The First Affiliated Hospital of Anhui Medical University) ;
  • Shao, En-Ming (The Municipal people's hospital of Maanshan) ;
  • Liang, Chao-Zhao (Department of Urology, The First Affiliated Hospital of Anhui Medical University)
  • Published : 2015.06.03
Download PDF
⟨ Previous Next ⟩

Abstract

Transient receptor potential melastain 7 (TRPM7) is a bifunctional protein with dual structure of both ion channel and protein kinase, participating in a wide variety of diseases including cancer. Recent researches have reported the mechanism of TRPM7 in human cancers. However, the correlation between TRPM7 and prostate cancer (PCa) has not been well studied. The objective of this study was to investigate the potential the role of TRPM7 in the apoptosis of PC-3 cells, which is the key cell of advanced metastatic PCa. In this study, we demonstrated the influence and potential function of TRPM7 on the PC-3 cells apoptosis induced by TNF-related apoptosis inducing-ligand (TRAIL). The study also found a novel up-regulated expression of TRPM7 in PC-3 cells after treating with TRAIL. Suppression of TRPM7 by TRPM7 non-specific inhibitors ($Gd^{3+}$ or 2-aminoethoxy diphenylborate (2-APB) ) not only markedly eliminated TRPM7 expression level, but also increased the apoptosis of TRAIL-treated PC-3 cells, which may be regulated by the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway accompany with up-regulated expression of cleaved Caspase-3, (TRAIL-receptor 1, death receptors 4) DR4, and (TRAIL-receptor 2, death receptors 5) DR5. Taken together, our findings strongly suggested that TRPM7 was involved in the apoptosis of PC-3 cells induced by TRAIL, indicating that TRPM7 may be applied as a therapeutic target for PCa.

Keywords

References

  1. Abed E, Moreau R (2007). Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif, 40, 849-65. https://doi.org/10.1111/j.1365-2184.2007.00476.x
  2. Allen JE, El-Deiry WS (2012). Regulation of the human TRAIL gene. Cancer Biol Ther, 13, 1143-51. https://doi.org/10.4161/cbt.21354
  3. Bodding M (2007). TRP proteins and cancer. Cell Signal, 19, 617-24. https://doi.org/10.1016/j.cellsig.2006.08.012
  4. Bucur O, Ray S, Bucur MC, et al (2006). APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Front Biosci, 11, 1549-68. https://doi.org/10.2741/1903
  5. Fang L, Zhan S, Huang C, et al (2013). TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharmacol, 272, 713-25. https://doi.org/10.1016/j.taap.2013.08.009
  6. Gaudet R (2008). A primer on ankyrin repeat function in TRP channels and beyond. Mol Biosyst, 4, 372-9. https://doi.org/10.1039/b801481g
  7. Guilbert A, Gautier M, Dhennin-Duthille I, et al (2013). Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur J Cancer, 49, 3694-707. https://doi.org/10.1016/j.ejca.2013.07.008
  8. Holoch PA, Griffith TS (2009). TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol, 625, 63-72. https://doi.org/10.1016/j.ejphar.2009.06.066
  9. Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  10. Jin J, Desai BN, Navarro B, et al (2008). Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering $Mg^{2+}$ homeostasis. Science, 322, 756-60. https://doi.org/10.1126/science.1163493
  11. Koschny R, Walczak H, Ganten TM (2007). The promise of TRAIL--potential and risks of a novel anticancer therapy. J Mol Med (Berl), 85, 923-35. https://doi.org/10.1007/s00109-007-0194-1
  12. Kunzelmann K (2005). Ion channels and cancer. J Membr Biol, 205, 159-73. https://doi.org/10.1007/s00232-005-0781-4
  13. Latorre R, Zaelzer C, Brauchi S (2009). Structure-functional intimacies of transient receptor potential channels. Q Rev Biophys, 42, 201-46. https://doi.org/10.1017/S0033583509990072
  14. Lehen'kyi V, Shapovalov G, Skryma R, et al (2011). Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. Am J Physiol Cell Physiol, 301, 1281-9.
  15. Lescarbeau RM, Kaplan DL (2014). Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling. BMC Cancer, 14, 325. https://doi.org/10.1186/1471-2407-14-325
  16. Minke B, Cook B (2002). TRP channel proteins and signal transduction. Physiol Rev, 82, 429-72. https://doi.org/10.1152/physrev.00001.2002
  17. Montell C (2005). The TRP superfamily of cation channels. Sci STKE, 2005, 3.
  18. Montell C, Birnbaumer L, Flockerzi V (2002). The TRP channels, a remarkably functional family. Cell, 108, 595-8. https://doi.org/10.1016/S0092-8674(02)00670-0
  19. Munshi A, Pappas G, Honda T, et al (2001). TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene, 20, 3757-65. https://doi.org/10.1038/sj.onc.1204504
  20. Nieminen AI, Partanen JI, Hau A, et al (2007). c-Myc primed mitochondria determine cellular sensitivity to TRAILinduced apoptosis. EMBO J, 26, 1055-67. https://doi.org/10.1038/sj.emboj.7601551
  21. Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, et al (2012). [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters]. Bull Cancer, 99, 655-64.
  22. Runnels LW, Yue L, Clapham DE (2001). TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science, 291, 1043-7. https://doi.org/10.1126/science.1058519
  23. Ryazanova LV, Rondon LJ, Zierler S, et al (2010). TRPM7 is essential for Mg(2+) homeostasis in mammals. Nat Commun, 1, 109. https://doi.org/10.1038/ncomms1108
  24. Sahni J, Scharenberg AM (2008). TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. Cell Metab, 8, 84-93. https://doi.org/10.1016/j.cmet.2008.06.002
  25. Saraswati S, Kumar S, Alhaider AA (2013). alpha-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. Mol Cancer, 12, 147. https://doi.org/10.1186/1476-4598-12-147
  26. Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
  27. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  28. Stuckey DW, Shah K (2013). TRAIL on trial: preclinical advances in cancer therapy. Trends Mol Med, 19, 685-94. https://doi.org/10.1016/j.molmed.2013.08.007
  29. Tannock IF, de Wit R, Berry WR, et al (2004). Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med, 351, 1502-12. https://doi.org/10.1056/NEJMoa040720
  30. Van Haute C, De Ridder D, Nilius B (2010). TRP channels in human prostate. ScientificWorldJournal, 10, 1597-611. https://doi.org/10.1100/tsw.2010.149
  31. Wang D, Lu J, Tindall DJ (2013). Androgens regulate TRAILinduced cell death in prostate cancer cells via multiple mechanisms. Cancer Lett, 335, 136-44. https://doi.org/10.1016/j.canlet.2013.02.001
  32. Wiley SR, Schooley K, Smolak PJ, et al (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-82. https://doi.org/10.1016/1074-7613(95)90057-8
  33. Yu M, Huang C, Huang Y, et al (2013). Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts. Inflamm Res, 62, 961-70. https://doi.org/10.1007/s00011-013-0653-9

Cited by

  1. Role of TRP ion channels in cancer and tumorigenesis vol.38, pp.3, 2016, https://doi.org/10.1007/s00281-015-0525-1
  2. New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements vol.74, pp.1, 2016, https://doi.org/10.1007/s12013-015-0712-7
  3. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth vol.38, pp.4, 2017, https://doi.org/10.3892/or.2017.5883
  4. TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-22852-2
  5. Ion channels as therapeutic antibody targets vol.11, pp.2, 2019, https://doi.org/10.1080/19420862.2018.1548232